134 related articles for article (PubMed ID: 9421684)
1. The role of lipoic acid in the treatment of diabetic polyneuropathy.
Biewenga G; Haenen GR; Bast A
Drug Metab Rev; 1997 Nov; 29(4):1025-54. PubMed ID: 9421684
[No Abstract] [Full Text] [Related]
2. [Biologic properties of lipoic acid].
Bilska A; Włodek L
Postepy Hig Med Dosw; 2002; 56(2):201-19. PubMed ID: 12107963
[TBL] [Abstract][Full Text] [Related]
3. Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study).
Tankova T; Koev D; Dakovska L
Rom J Intern Med; 2004; 42(2):457-64. PubMed ID: 15529636
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy and safety of high-dose α-lipoic acid in the treatment of diabetic polyneuropathy].
Gu XM; Zhang SS; Wu JC; Tang ZY; Lu ZQ; Li H; Liu C; Chen L; Ning G
Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(35):2473-6. PubMed ID: 21092474
[TBL] [Abstract][Full Text] [Related]
5. [Diabetic polyneuropathy. Sequential therapy with alpha-lipoic acid passes the general practice test].
Hedding-Eckerich M; Eckert MW
MMW Fortschr Med; 2000 Sep; 142(36):38. PubMed ID: 11021068
[No Abstract] [Full Text] [Related]
6. [Alpha-lipoic acid in diabetic neuropathy. Action mechanism and therapy. Clinical picture and pathogenesis of diabetic neuropathy].
Internist (Berl); 1994 Jun; 35(6 Alpha-liponsa):1-4. PubMed ID: 9532228
[No Abstract] [Full Text] [Related]
7. Clinical experience with thioctacid (thioctic acid) in the treatment of distal symmetric polyneuropathy in Korean diabetic patients.
Hahm JR; Kim BJ; Kim KW
J Diabetes Complications; 2004; 18(2):79-85. PubMed ID: 15120701
[TBL] [Abstract][Full Text] [Related]
8. Effects of 3-month treatment with the antioxidant alpha-lipoic acid in diabetic peripheral neuropathy.
Negrişanu G; Roşu M; Bolte B; Lefter D; Dabelea D
Rom J Intern Med; 1999; 37(3):297-306. PubMed ID: 15532308
[TBL] [Abstract][Full Text] [Related]
9. The function of endogenous protective systems in patients with insulin-dependent diabetes mellitus and polyneuropathy: effect of antioxidant therapy.
Strokov IA; Manukhina EB; Bakhtina LY; Malyshev IY; Zoloev GK; Kazikhanova SI; Ametov AS
Bull Exp Biol Med; 2000 Oct; 130(10):986-90. PubMed ID: 11177301
[TBL] [Abstract][Full Text] [Related]
10. Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes.
Koçak G; Aktan F; Canbolat O; Ozoğul C; Elbeğ S; Yildizoglu-Ari N; Karasu C;
Diabetes Nutr Metab; 2000 Dec; 13(6):308-18. PubMed ID: 11232755
[TBL] [Abstract][Full Text] [Related]
11. Treatment of diabetic polyneuropathy with alpha-lipoic acid is evidence based.
Vereşiu IA
Rom J Intern Med; 2004; 42(2):293-9. PubMed ID: 15529620
[TBL] [Abstract][Full Text] [Related]
12. Alpha-lipoic acid treatment prevents the diabetes-induced attenuation of the afferent limb of the baroreceptor reflex in rats.
Gouty S; Regalia J; Cai F; Helke CJ
Auton Neurosci; 2003 Oct; 108(1-2):32-44. PubMed ID: 14614962
[TBL] [Abstract][Full Text] [Related]
13. The effect of alpha-lipoic acid on the neurovascular reflex arc in patients with diabetic neuropathy assessed by capillary microscopy.
Haak ES; Usadel KH; Kohleisen M; Yilmaz A; Kusterer K; Haak T
Microvasc Res; 1999 Jul; 58(1):28-34. PubMed ID: 10388600
[TBL] [Abstract][Full Text] [Related]
14. The effect of alpha-lipoic acid on symptoms and skin blood flow in diabetic neuropathy.
Jin HY; Joung SJ; Park JH; Baek HS; Park TS
Diabet Med; 2007 Sep; 24(9):1034-8. PubMed ID: 17490418
[TBL] [Abstract][Full Text] [Related]
15. [α-Lipoic acid as the main pharmacological drug for in- and outpatient treatment of diabetic polyneuropathy].
Strokov IA; Phokina AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(3):50-55. PubMed ID: 28399096
[TBL] [Abstract][Full Text] [Related]
16. A current update on the use of alpha lipoic acid in the management of type 2 diabetes mellitus.
Poh ZX; Goh KP
Endocr Metab Immune Disord Drug Targets; 2009 Dec; 9(4):392-8. PubMed ID: 19601918
[TBL] [Abstract][Full Text] [Related]
17. [Drug treatment of diabetic polyneuropathy with alpha-lipoic acid or vitamin B preparations. A clinical and neurophysiologic study].
Jörg J; Metz F; Scharafinski H
Nervenarzt; 1988 Jan; 59(1):36-44. PubMed ID: 2832774
[No Abstract] [Full Text] [Related]
18. Diabetic polyneuropathy: the importance of insulin deficiency, hyperglycemia and alterations in myoinositol metabolism in its pathogenesis.
Winegrad AI; Greene DA
N Engl J Med; 1976 Dec; 295(25):1416-21. PubMed ID: 980097
[No Abstract] [Full Text] [Related]
19. Pretreatment of diabetic rats with lipoic acid improves healing of subsequently-induced abrasion wounds.
Lateef H; Aslam MN; Stevens MJ; Varani J
Arch Dermatol Res; 2005 Aug; 297(2):75-83. PubMed ID: 15986218
[TBL] [Abstract][Full Text] [Related]
20. [Alpha-lipoic acid in the treatment of diabetic polyneuropathy].
Chukanova EI; Chukanova AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(1):103-109. PubMed ID: 29460914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
